Back
ESC Professional Premium Access

Mechanisms of the clinical benefits of SGLT2i in heart failure (EMPEROR-Pooled)

Session: Late-Breaking Science - Innovations in drug treatment
Topic: Pharmacotherapy
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
100 presentations
4 followers

3 more presentations in this session

Lifetime prediction and Treatment Benefit in HFrEF (LIFE-HF).

Speaker: Doctor S. Koudstaal (Gouda, NL)

Access
Slides
Video
Thumbnail

Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial

Speaker: Doctor B. Ingraham (Rochester, US)

Access
Slides
Video
Thumbnail

ENTRIGUE: Pegozafermin for the treatment of severe hypertriglyceridemia.

Speaker: Professor D. Bhatt (New York, US)

Access
Slides
Video
Thumbnail

Access the full session

Late-Breaking Science - Innovations in drug treatment

Speakers: Professor F. Zannad, Doctor S. Koudstaal, Doctor B. Ingraham, Professor D. Bhatt
Access
Video
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb